Last reviewed · How we verify
Standard dose rifapentine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard dose rifapentine (Standard dose rifapentine) — McGill University Health Centre/Research Institute of the McGill University Health Centre.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard dose rifapentine TARGET | Standard dose rifapentine | McGill University Health Centre/Research Institute of the McGill University Health Centre | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard dose rifapentine CI watch — RSS
- Standard dose rifapentine CI watch — Atom
- Standard dose rifapentine CI watch — JSON
- Standard dose rifapentine alone — RSS
Cite this brief
Drug Landscape (2026). Standard dose rifapentine — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-dose-rifapentine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab